193 related articles for article (PubMed ID: 27752996)
1. PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma.
Hua Z; Gu X; Dong Y; Tan F; Liu Z; Thiele CJ; Li Z
Tumour Biol; 2016 Oct; 37(12):16227-36. PubMed ID: 27752996
[TBL] [Abstract][Full Text] [Related]
2. Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
Li Z; Oh DY; Nakamura K; Thiele CJ
Cancer; 2011 Dec; 117(23):5412-22. PubMed ID: 21590687
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
4. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
Li Z; Tan F; Thiele CJ
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
[TBL] [Abstract][Full Text] [Related]
6. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
[TBL] [Abstract][Full Text] [Related]
7. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A Alleviates Oxidative Glutamate Toxicity in Hippocampal HT22 Cells via Activating BDNF/TrkB-Dependent PI3K/Akt/mTOR Signaling Pathway.
Mao XY; Zhou HH; Li X; Liu ZQ
Cell Mol Neurobiol; 2016 Aug; 36(6):915-925. PubMed ID: 26440805
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ
Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748
[TBL] [Abstract][Full Text] [Related]
10. Baicalin Attenuates Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron-Astrocyte Cocultures.
Li C; Sui C; Wang W; Yan J; Deng N; Du X; Cheng F; Ma X; Wang X; Wang Q
Front Pharmacol; 2021; 12():599543. PubMed ID: 34234667
[No Abstract] [Full Text] [Related]
11. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
12. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
Yu X; Fan H; Jiang X; Zheng W; Yang Y; Jin M; Ma X; Jiang W
Oncol Lett; 2020 Oct; 20(4):52. PubMed ID: 32788939
[TBL] [Abstract][Full Text] [Related]
13. GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models.
Zou J; Zhang Z; Xu F; Cui S; Qi C; Luo J; Wang Z; Lu X; Tu Z; Ren X; Song L; Ding K
J Drug Target; 2019 Apr; 27(4):442-450. PubMed ID: 30301369
[TBL] [Abstract][Full Text] [Related]
14. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
[TBL] [Abstract][Full Text] [Related]
15. The Bu Shen Yi Sui Formula Promotes Axonal Regeneration
Zheng Q; Liu L; Liu H; Zheng H; Sun H; Ji J; Sun Y; Yang T; Zhao H; Qi F; Li K; Li J; Zhang N; Fan Y; Wang L
Front Pharmacol; 2019; 10():796. PubMed ID: 31379571
[TBL] [Abstract][Full Text] [Related]
16. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
Kawamura K; Kawamura N; Okamoto N; Manabe M
Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
[TBL] [Abstract][Full Text] [Related]
17. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
[TBL] [Abstract][Full Text] [Related]
19. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
